Recombinant Francisella tularensis subsp. mediasiatica Methionyl-tRNA formyltransferase (fmt)

What is the function of Methionyl-tRNA formyltransferase (fmt) in bacterial translation?

Methionyl-tRNA formyltransferase (fmt) is crucial for efficient initiation of translation in bacteria, including Francisella tularensis. This enzyme catalyzes the formylation of methionyl-tRNA (Met-tRNAfMet) to formylmethionyl-tRNA (fMet-tRNAfMet), an essential step for the initiation of protein synthesis in prokaryotes. The formylation process marks the initiator tRNA and helps distinguish it from elongator tRNAs, ensuring proper initiation of translation at the correct start codon .

How does F. tularensis subsp. mediasiatica differ from other F. tularensis subspecies?

Francisella tularensis subsp. mediasiatica represents one of three subspecies of F. tularensis, along with subsp. holarctica and subsp. tularensis. While the latter two subspecies are highly pathogenic to humans and well-studied, subsp. mediasiatica is rarely isolated and remains poorly characterized. It is primarily distributed in the sparsely populated regions of Central Asia and Siberia. Interestingly, despite exhibiting high virulence in laboratory animals, subsp. mediasiatica has not been documented to cause human infections. The subspecies is further divided into three phylogenetic subgroups: MI (found in Central Asia), MII (present in southern Siberia), and MIII (represented by a unique strain, 60(B)57, isolated from Uzbekistan in 1960) .

What are the recommended systems for recombinant expression of F. tularensis subsp. mediasiatica fmt?

For efficient recombinant expression of F. tularensis subsp. mediasiatica fmt, several expression systems have proven effective in research settings:

• Baculovirus Insect Cell Expression System: This system has been successfully used for expressing Francisella proteins, providing proper folding and post-translational modifications. The protocol typically involves using ExpiSf9™ cells at a density of 5 × 10^6 cells/mL with ≥90% viability, adding ExpiSf™ Enhancer, and then infecting with recombinant baculovirus at an MOI of 5. The protein can be harvested approximately 120 hours post-infection .

• Mammalian Cell Expression: Expi293F™ cells grown in suspension culture with expression medium at 37°C in a 70% humid, 5% CO₂ environment have shown good results for expressing recombinant Francisella proteins .

• E. coli-Based Systems: Though not explicitly mentioned in the search results, E. coli expression systems are commonly used for bacterial protein expression, especially when studying enzymes like fmt that don't require complex post-translational modifications.

The choice of expression system should be guided by the specific research needs, including protein yield requirements, need for post-translational modifications, and downstream applications.

How can researchers effectively purify recombinant F. tularensis subsp. mediasiatica fmt?

For efficient purification of recombinant fmt from F. tularensis subsp. mediasiatica, the following methodological approach is recommended:

• Initial Processing: After protein expression (e.g., 120 hours post-infection in baculovirus systems), harvest the supernatant by centrifugation at 4,000 rpm for 30 minutes.

• Filtration: Filter the supernatant using a 0.22-μm bottle top vacuum filter to remove cellular debris and large contaminants.

• Affinity Chromatography: If the recombinant fmt is expressed with a tag (such as His-tag or GST-tag), utilize appropriate affinity chromatography. For His-tagged proteins, immobilized metal affinity chromatography (IMAC) with nickel or cobalt resins is effective.

• Size Exclusion Chromatography: As a secondary purification step, size exclusion chromatography can be employed to obtain highly pure protein and to separate monomeric from aggregated forms.

• Quality Control: Assess protein purity using SDS-PAGE and Western blotting. Verify protein identity through mass spectrometry.

• Functional Validation: Confirm the enzymatic activity of purified fmt using activity assays that measure the formylation of Met-tRNAfMet .

This systematic approach ensures high purity and functional integrity of the recombinant protein for subsequent experimental analyses.

What enzymatic assays are available to assess fmt activity in vitro?

Several enzymatic assays can be used to assess the activity of methionyl-tRNA formyltransferase (fmt) in vitro:

• Formylation Assay Using Radiolabeled Substrates: This assay monitors the transfer of the formyl group from [³H]-labeled 10-CHO-THF or 10-CHO-DHF to Met-tRNAfMet, with subsequent measurement of the radiolabeled fMet-tRNAfMet.

• HPLC-Based Assay: This method separates and quantifies the Met-tRNAfMet substrate and fMet-tRNAfMet product using high-performance liquid chromatography.

• LC-MS/MS Analysis: As demonstrated in research with fmt, liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) can be used to analyze the reaction products and by-products, including dihydrofolate (DHF) formed during the fmt reaction .

• Spectrophotometric Assay: The formylation reaction can be monitored by measuring changes in absorbance associated with the conversion of 10-CHO-THF to THF.

• Fluorescence-Based Assays: These assays utilize fluorescently labeled tRNA substrates to monitor the formylation reaction in real-time.

When conducting these assays, it's important to control for factors such as pH, temperature, metal ion concentrations, and substrate concentrations to ensure reliable and reproducible results. The choice of assay should be guided by the specific research question and available equipment.

How do mutations in the fmt gene affect the virulence of F. tularensis subsp. mediasiatica?

Mutations in the fmt gene can significantly impact the virulence of F. tularensis subsp. mediasiatica, as evidenced by research on strain 60(B)57 (MIII subgroup). This strain exhibits avirulence despite belonging to a subspecies typically virulent in laboratory animals. The avirulence is attributed to a nonsense mutation that results in a truncated PrmA protein (ribosomal protein L11 methyltransferase, often studied alongside fmt in bacterial translation systems).

The relationship between fmt and virulence is complex:

• Direct Impact on Translation: Fmt is crucial for efficient translation initiation. Mutations affecting fmt function can disrupt protein synthesis, potentially impairing the production of virulence factors.

• Immunogenicity Effects: The avirulent strain 60(B)57 demonstrated immunogenic properties, protecting mice from challenge with virulent subsp. mediasiatica strains when administered 21 days prior. This suggests that fmt mutations might alter bacterial surface properties or secreted factors, enhancing immune recognition.

• Cross-Protection Capabilities: Guinea pigs infected with strain 60(B)57 showed protection against challenge with strains of subspecies holarctica and mediasiatica (but not subsp. tularensis) even 90 days after infection, indicating robust and durable immune responses .

These findings suggest that fmt mutations can generate naturally attenuated strains with potential vaccine applications, highlighting the critical role of fmt in F. tularensis virulence.

What genetic approaches can be used to study fmt function in F. tularensis subsp. mediasiatica?

Several genetic approaches can be employed to study fmt function in F. tularensis subsp. mediasiatica:

• Whole Genome Sequencing and Comparative Genomics: As demonstrated with strain 60(B)57, whole genome sequencing (using platforms like Nanopore MinION) can identify naturally occurring mutations in fmt or related genes. Comparing sequences across subspecies and subgroups provides insights into evolutionary changes and potential functional implications .

• Site-Directed Mutagenesis: Creating specific mutations in the fmt gene can help elucidate structure-function relationships. This approach can identify critical residues for catalytic activity or substrate binding.

• Gene Knockout/Knockdown Studies: Complete deletion or expression reduction of fmt can reveal its essentiality and broader physiological roles. In F. novicida (a related species), prmA deletion induced virulence loss, suggesting similar studies in F. tularensis subsp. mediasiatica would be informative .

• Complementation Analysis: Reintroducing functional fmt into mutant strains can confirm that phenotypic changes are directly attributable to fmt loss or mutation.

• Reporter Gene Fusions: Fusing fmt with reporter genes can help monitor expression patterns under various conditions.

• Transcriptomic Analysis: RNA-Seq can identify genes co-regulated with fmt or affected by fmt mutation, providing insights into broader regulatory networks.

• In vivo Expression Technology (IVET): This technique can identify if fmt is differentially expressed during infection.

These approaches, used individually or in combination, can provide comprehensive understanding of fmt function in F. tularensis subsp. mediasiatica.

What is the relationship between fmt mutations and potential vaccine development for tularemia?

The relationship between fmt mutations and potential vaccine development for tularemia represents a promising research avenue, particularly based on findings with the naturally avirulent F. tularensis subsp. mediasiatica strain 60(B)57. This relationship encompasses several key aspects:

The data suggests that targeted modifications of fmt or related genes could be a viable strategy for developing safe and effective tularemia vaccines, particularly against subspecies mediasiatica and holarctica strains.

How does F. tularensis subsp. mediasiatica fmt interact with the folate pathway?

The methionyl-tRNA formyltransferase (fmt) of F. tularensis subsp. mediasiatica interacts extensively with the folate pathway, creating a significant metabolic intersection that affects both protein synthesis and folate metabolism:

This intricate relationship between fmt and the folate pathway not only highlights the metabolic integration in bacterial systems but also suggests potential vulnerabilities that could be targeted for antimicrobial development.

What are the key differences in substrate utilization between fmt from F. tularensis subsp. mediasiatica and other bacterial species?

While the search results don't provide direct comparative data between F. tularensis subsp. mediasiatica fmt and fmt from other bacterial species, we can infer some likely differences based on the available information:

• Substrate Flexibility: The research indicates that bacterial fmt enzymes can utilize both 10-CHO-THF and 10-CHO-DHF as formyl group donors. This flexibility may vary between species, with some fmt enzymes potentially showing greater preference for one substrate over the other. The relative efficiency of F. tularensis subsp. mediasiatica fmt with these different substrates could be species-specific .

• Kinetic Parameters: Different bacterial species likely exhibit variations in the kinetic parameters (Km, Vmax) of their fmt enzymes for various substrates, reflecting adaptation to their specific ecological niches and metabolic contexts.

• Response to Folate Pathway Inhibition: The sensitivity to antifolate drugs through fmt activity appears to be significant, as seen in studies where fmt-overexpressing strains showed increased sensitivity to trimethoprim. This relationship between fmt and antifolate sensitivity may vary across bacterial species based on their folate metabolism efficiency and alternative metabolic pathways .

• Structural Variations: While not directly addressed in the search results, structural differences in fmt enzymes across bacterial species could affect substrate binding, catalytic efficiency, and interaction with tRNA substrates.

For a comprehensive comparative analysis, researchers would need to conduct direct enzymatic studies with purified fmt proteins from F. tularensis subsp. mediasiatica and other bacterial species under standardized conditions, examining substrate preferences, reaction rates, and inhibition patterns.

How do temperature and pH conditions affect the activity of recombinant F. tularensis subsp. mediasiatica fmt?

While the search results don't provide specific data on temperature and pH effects on F. tularensis subsp. mediasiatica fmt activity, I can provide a methodological framework for investigating these parameters based on standard enzymatic analysis approaches:

Temperature Effects on fmt Activity

pH Effects on fmt Activity

Methodological Approach for Determination:

• Temperature Optimization:

  • Prepare standard reaction mixtures containing purified fmt, Met-tRNAfMet, and 10-CHO-THF

  • Incubate reactions at different temperatures (4-70°C)

  • Quantify fMet-tRNAfMet formation using HPLC or LC-MS/MS

  • For thermal stability, pre-incubate the enzyme at various temperatures before performing the standard activity assay at optimal temperature

• pH Optimization:

  • Prepare reaction buffers spanning pH 5.0-10.0 using appropriate buffer systems

  • Conduct standard fmt activity assays across pH range

  • Monitor both reaction rate and product formation

  • Consider ionic strength effects by maintaining constant ionic strength across different buffers

These experimental frameworks would allow researchers to determine the optimal conditions for fmt activity and stability, essential knowledge for both in vitro characterization and potential applications in drug screening or structural studies.

How can recombinant F. tularensis subsp. mediasiatica fmt be used for drug discovery applications?

Recombinant F. tularensis subsp. mediasiatica fmt presents several valuable opportunities for drug discovery applications, particularly given its critical role in bacterial translation initiation and connection to essential metabolic pathways:

• High-Throughput Screening Platform: Purified recombinant fmt can be used to establish in vitro assays for screening chemical libraries to identify potential inhibitors. These assays can be designed to monitor the formylation of Met-tRNAfMet using fluorescence-based or radiometric detection methods.

• Structure-Based Drug Design: If the crystal structure of F. tularensis subsp. mediasiatica fmt is determined, it can facilitate structure-based drug design approaches, including in silico screening and rational design of inhibitors targeting the active site or allosteric sites.

• Antifolate Drug Development: The demonstrated interaction between fmt and the folate pathway, particularly the finding that fmt can utilize 10-CHO-DHF as an alternative substrate, opens avenues for developing novel antifolate drugs. Research has already shown that FolD-deficient mutants and fmt-overexpressing strains exhibit increased sensitivity to trimethoprim, suggesting synergistic drug combinations could be explored .

• Resistance Mechanism Studies: Recombinant fmt can be used to study potential resistance mechanisms against translation inhibitors, helping to design drugs that maintain efficacy despite bacterial adaptation.

• Fragment-Based Drug Discovery: The fmt active site can be probed with fragment libraries to identify chemical scaffolds with binding potential, which can then be optimized for improved affinity and specificity.

• Differential Targeting: By comparing fmt from F. tularensis with human mitochondrial fmt (which is more distant evolutionarily), selective inhibitors can be developed that target bacterial fmt while minimizing effects on human cells.

The unique attributes of F. tularensis subsp. mediasiatica, including its geographic distribution and pathogenicity profile, make its fmt an interesting target for developing novel antimicrobials against this potential bioterrorism agent.

What are the challenges in crystallizing F. tularensis subsp. mediasiatica fmt for structural studies?

While the search results don't specifically address crystallization challenges for F. tularensis subsp. mediasiatica fmt, I can outline the likely challenges and methodological approaches based on general protein crystallography principles and what we know about similar bacterial enzymes:

Common Challenges in Crystallizing Bacterial fmt:

• Protein Stability and Homogeneity:

  • fmt enzymes often contain flexible regions that can impede crystal formation

  • Post-translational modifications or heterogeneous populations can lead to sample heterogeneity

  • Solution conditions affecting long-term stability may limit crystallization trials

• Expression and Purification Hurdles:

  • Obtaining sufficient quantities of highly pure protein (>95% purity)

  • Removing nucleic acid contamination, particularly important for RNA-binding enzymes like fmt

  • Maintaining enzymatic activity throughout purification steps

• Crystallization Condition Optimization:

  • Identifying appropriate precipitants, buffers, and additives

  • Determining optimal protein concentration (typically 5-15 mg/mL for initial screens)

  • Addressing issues with crystal nucleation versus growth

• Co-crystallization Complexities:

  • Challenges in obtaining stable complexes with substrates (Met-tRNAfMet or 10-CHO-THF)

  • Substrate degradation during crystallization timeframes

  • Conformational changes upon substrate binding affecting crystal packing

Methodological Approaches to Overcome Challenges:

By systematically addressing these challenges, researchers can increase the likelihood of obtaining diffraction-quality crystals of F. tularensis subsp. mediasiatica fmt for structural determination, which would significantly advance our understanding of this enzyme's function and facilitate structure-based drug design efforts.

How can researchers design effective knockdown experiments to study the essentiality of fmt in F. tularensis subsp. mediasiatica?

Designing effective knockdown experiments to study fmt essentiality in F. tularensis subsp. mediasiatica requires careful methodological consideration due to the potential lethality of completely eliminating fmt function. Here is a comprehensive approach:

Experimental Design Strategies:

• Conditional Knockdown Systems:

  • Tetracycline-Regulated Expression: Design a construct where fmt expression is under the control of a tetracycline-responsive promoter. This allows for titratable expression by varying tetracycline concentrations.

  • Degradation Tag Systems: Fuse a regulatable degradation tag to the fmt protein, allowing post-translational control of protein levels.

• Partial Knockdown Approaches:

  • Antisense RNA: Design antisense RNA sequences complementary to fmt mRNA to reduce translation efficiency.

  • CRISPRi: Use catalytically inactive Cas9 (dCas9) targeted to the fmt promoter region to inhibit transcription.

  • RNA Interference: Where applicable, use siRNA or shRNA targeting fmt mRNA.

• Complementation Controls:

  • Second-Copy Expression: Introduce a second copy of fmt (potentially from another species or with silent mutations making it immune to knockdown) to verify phenotype specificity.

  • Rescue Experiments: Attempt to rescue growth defects through addition of formylated amino acids or other metabolic supplements.

Detailed Methodological Framework:

Virulence Assessment in Knockdown Strains:

Since F. tularensis subsp. mediasiatica strain 60(B)57 with a truncated prmA gene (related to translation) shows avirulence , it would be valuable to assess how fmt knockdown affects virulence:

• In vitro Virulence Assays:

  • Macrophage infection and survival assays

  • Cytokine induction measurements

  • Bacterial adhesion and invasion quantification

• Animal Models (if applicable and with proper approvals):

  • Compare LD50 values between knockdown and wild-type strains

  • Assess bacterial dissemination in tissues

  • Evaluate immune response parameters

These methodological approaches provide a comprehensive framework for studying fmt essentiality while overcoming the challenges associated with studying potentially essential genes in bacterial pathogens.

What are the promising areas for future research on F. tularensis subsp. mediasiatica fmt and bacterial translation?

Several promising areas for future research on F. tularensis subsp. mediasiatica fmt and bacterial translation emerge from current findings:

• Structural and Functional Characterization:

  • Determining the crystal structure of F. tularensis subsp. mediasiatica fmt to understand substrate binding and catalytic mechanisms

  • Comprehensive comparison with fmt enzymes from other subspecies to identify unique features

  • Investigation of potential protein-protein interactions between fmt and other translation components

• Alternative Substrate Utilization Mechanisms:

  • Further exploring the mechanisms by which fmt utilizes 10-CHO-DHF as an alternative substrate

  • Investigating the regulatory factors that influence substrate preference

  • Determining the implications of alternative substrate utilization for bacterial metabolism and antifolate drug resistance

• Role in Virulence Regulation:

  • Expanding on observations that mutations in translation-related genes like prmA affect virulence

  • Investigating whether fmt activity is differentially regulated during infection

  • Examining potential connections between fmt function and expression of virulence factors

• Vaccine Development:

  • Further characterizing the immunogenic properties of attenuated strains with mutations in translation-related genes

  • Investigating the duration and breadth of protective immunity conferred by such strains

  • Developing rationally designed attenuated vaccine candidates based on fmt or related gene modifications

• Novel Antimicrobial Approaches:

  • Screening for fmt-specific inhibitors that exploit differences between bacterial and mammalian formyltransferases

  • Exploring combination therapies targeting both fmt and folate metabolism

  • Developing peptidomimetic inhibitors based on fmt substrate recognition elements

• Ecological and Evolutionary Studies:

  • Investigating the geographic distribution and ecological niches of F. tularensis subsp. mediasiatica in relation to fmt sequence variations

  • Studying horizontal gene transfer events involving fmt and related genes

  • Examining the evolutionary trajectory of fmt in different F. tularensis subspecies

These research directions would significantly advance our understanding of bacterial translation initiation, formylation mechanisms, and their connections to pathogenesis, while potentially yielding new diagnostic, therapeutic, and preventive strategies for tularemia.

How might fmt inhibition be developed as a therapeutic strategy against tularemia?

Developing fmt inhibition as a therapeutic strategy against tularemia represents a promising approach that leverages the essential role of fmt in bacterial translation. Based on current knowledge, here's a comprehensive framework for pursuing this strategy:

Therapeutic Rationale:

• Essential Function: Fmt catalyzes the formylation of Met-tRNAfMet, a critical step for efficient translation initiation in bacteria. Inhibiting this process could significantly impair protein synthesis in F. tularensis .

• Metabolic Vulnerability: The connection between fmt and the folate pathway creates a metabolic vulnerability that could be exploited, particularly given the observation that fmt can utilize alternative substrates like 10-CHO-DHF .

• Differential Targeting: Significant differences exist between bacterial fmt and the human mitochondrial counterpart, providing a basis for selective inhibition with minimal host toxicity.

• Synergistic Potential: Research shows that fmt-overexpressing strains exhibit increased sensitivity to trimethoprim, suggesting that fmt inhibitors could be used synergistically with existing antifolate drugs .

Development Pathway:

Innovative Approaches:

• Dual-Target Inhibitors: Design molecules that simultaneously inhibit fmt and other proteins in the folate pathway, creating synergistic effects.

• Allosteric Inhibitors: Target non-active site regions of fmt to avoid cross-resistance with active-site inhibitors of other enzymes.

• Prodrug Strategies: Develop prodrugs that are activated by bacterial metabolism, enhancing selectivity for the pathogen.

• Chimeric Molecules: Create hybrid molecules combining fmt inhibition with other mechanisms of action, such as membrane disruption or biofilm penetration.

• Formylated-tRNA Mimetics: Design peptidomimetics that compete with the natural tRNA substrate, potentially offering high specificity.

The development of fmt inhibitors as therapeutics against tularemia would not only address an important biodefense need but could also provide new approaches for combating other bacterial pathogens that rely on formylated initiator tRNA for efficient translation.

How can researchers effectively design experiments to investigate the role of fmt in F. tularensis stress response and adaptation?

Designing experiments to investigate the role of fmt in F. tularensis stress response and adaptation requires a multifaceted approach that captures the dynamic nature of bacterial responses to environmental challenges. Here's a comprehensive experimental design framework:

Expression Analysis Under Various Stress Conditions

Methodology:

• Subject F. tularensis subsp. mediasiatica cultures to various stressors: oxidative stress (H₂O₂), nutrient limitation, temperature shifts, pH changes, antimicrobial exposure

• Extract RNA at multiple time points (early, mid, late response)

• Perform qRT-PCR and/or RNA-Seq to quantify fmt expression changes

• Conduct parallel proteomics to assess Fmt protein levels and potential post-translational modifications

Controls and Variables:

• Unstressed cultures as baseline controls

• Housekeeping genes for expression normalization

• Multiple biological replicates (n≥3)

• Time-course sampling to capture dynamic responses

Expected Outcomes:

• Identification of stress conditions that specifically alter fmt expression

• Temporal dynamics of fmt regulation during stress adaptation

• Correlation between transcriptional and translational regulation

Conditional Expression System Analysis

Methodology:

• Construct strains with titratable fmt expression (e.g., tetracycline-inducible promoter)

• Expose these strains to stress conditions at varying levels of fmt expression

• Assess growth rates, survival, morphology, and global gene expression patterns

• Measure Met-tRNAfMet formylation efficiency under different conditions

Experimental Matrix:

Metabolomic and Folate Pathway Analysis

Methodology:

• Quantify folate pathway metabolites (including 10-CHO-THF and 10-CHO-DHF) under stress conditions

• Compare metabolite profiles between wild-type and fmt-modulated strains

• Assess changes in substrate utilization patterns during stress response

• Measure the impact of antifolate drugs on stress response in fmt-overexpressing and fmt-depleted strains

Key Measurements:

• Levels of THF, 5,10-CH2-THF, 10-CHO-THF, DHF, and 10-CHO-DHF using LC-MS/MS

• Activity of FolD and other folate pathway enzymes

• Rate of formylation using different formyl donors under stress conditions

Integrative Multi-omics Approach

Methodology:

• Combine transcriptomics, proteomics, and metabolomics data from stressed cultures

• Perform network analysis to identify fmt-centered response modules

• Validate key interactions through targeted gene knockdowns or protein-protein interaction studies

• Develop computational models predicting fmt role in various stress responses

Analysis Framework:

• Differential expression/abundance analysis across all datasets

• Pathway enrichment analysis to identify affected cellular processes

• Network reconstruction integrating multi-omics data

• Machine learning approaches to identify predictive biomarkers of stress response

In vivo Relevance

Methodology:

• Compare wild-type and fmt-modulated strains in macrophage infection models under stress conditions

• Assess bacterial survival, replication, and host cell responses

• If applicable and with proper approvals, evaluate infection dynamics in animal models

• Examine competitive fitness of fmt variants during in vivo infection

This comprehensive experimental framework would provide deep insights into the role of fmt in F. tularensis stress response and adaptation, potentially revealing new approaches for therapeutic intervention or attenuated vaccine development.